Companies /Consumer Cyclical

Starbucks Corp

NASDAQ: SBUX Restaurants
$104.40
▲ $0.73 (+0.70%) today
Markets open · 12:34pm ET

SBUX Coverage Page 22

8:13am ET
Companies and Brands

Nestle Adds Peanut Allergy Treatment to Its Portfolio

Consumer products giant Nestlé has agreed to acquire Aimmune Therapeutics, maker of a peanut-allergy treatment. The deal is valued at $2.6 billion, including Nestlé's existing stake Aimmune.

Paul Ausick